The modulation of vascular ATP-sensitive K+ channel function via the phosphatidylinositol 3-kinase-Akt pathway activated by phenylephrine

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 2, 2010, Pages 673-678

  Haba, Masanori ^a   Hatakeyama, Noboru ^b   Kinoshita, Hiroyuki ^a   Teramae, Hiroki ^c   Azma, Toshiharu ^d   Hatano, Yoshio ^a   Matsuda, Naoyuki ^c  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 MORPHOLINO 8 PHENYLCHROMONE; ADENOSINE TRIPHOSPHATE; LEMAKALIM; PHENTOLAMINE; PHENYLEPHRINE; PHOSPHATIDYLINOSITOL 3 KINASE; POTASSIUM CHANNEL; PROTEIN KINASE B; SERINE; THREONINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HEART CONTRACTION; HEART MUSCLE RELAXATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; AORTA; KATP CHANNELS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PATCH-CLAMP TECHNIQUES; PHENYLEPHRINE; PHOSPHORYLATION; PROTEIN SUBUNITS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 77954916348     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.167775     Document Type: Article

References (19)

1. Domin J and Waterfield MD (1997) Using structure to define the function of phosphoinositide 3-kinase family members. FEBS Lett 410:91-95. (Pubitemid 27283391)
2. Hayabuchi Y, Willars GB, Standen NB, and Davies NW (2008) Insulin-like growth factor-1 inhibits rat arterial KATP channels through pI 3-kinase. Biochem Biophys Res Commun 374:742-746.
3. + channel function impaired by high glucose in the human artery. Hypertension 52:507-513.
4. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
5. 2+ channels. Circ Res 89:692-699.
6. Matsuda N, Hayashi Y, Takahashi Y, and Hattori Y (2006) Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy. J Pharmacol Exp Ther 319:1348-1354.
7. Morello F, Perino A, and Hirsch E (2009) Phosphoinositide 3-kinase signaling in the vascular system. Cardiovasc Res 82:261-271.
8. Northcott CA, Poy MN, Najjar SM, and Watts SW (2002) Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circ Res 91:360-369.
9. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, and Backx PH (2004) The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 37:449-471.
10. 1A-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 364:444-453.
11. Quayle JM, Nelson MT, and Standen NB (1997) ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 77:1165-1232. (Pubitemid 27459582)
12. Sata M and Nagai R (2002) Phosphatidylinositol 3-kinase: a key regulator of vascular tone? Circ Res 91:273-275.
13. + channels in the function of rat aortic smooth muscle cells. Br J Pharmacol 143:303-317.
14. Vanhaesebroeck B, Ali K, Bilancio A, Geering B, and Foukas LC (2005) Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem Sci 30:194-204.
15. Vecchione C, Patrucco E, Marino G, Barberis L, Poulet R, Aretini A, Maffei A, Gentile MT, Storto M, Azzolino O, et al. (2005) Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kγ. J Exp Med 201:1217-1228.
16. Wenzel S, Abdallah Y, Helmig S, Schäfer C, Piper HM, and Schlüter KD (2006) Contribution of PI 3-kinase isoforms to angiotensin II- and α-adrenoceptor-mediated signaling pathways in cardiomyocytes. Cardiovasc Res 71:352-362.
17. 13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nature Med 14:64-68.
18. Yoshida H, Feig JE, Morrissey A, Ghiu IA, Artman M, and Coetzee WA (2004) KATP channels of primary human coronary artery endothelial cells consist of a heteromultimeric complex of Kir6.1, Kir6.2, and SUR2B subunits. J Mol Cell Cardiol 37:857-869.
19. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, and Backer JM (1998) Regulation of the p85/p110 phosphatidylinositol 3′-kinase: stabilization and inhibition of the p110α catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 18:1379-1387.